---
$id: https://graph.org.ai/products/commodity/51111635
$type: Product
source: UNSPSC
code: "51111635"
title: "Eniluracil"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Eniluracil

**UNSPSC Code**: 51111635
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist and dihydropyrimidine dehydrogenase inhibitor with the molecular formula C6H4N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2E2W0W5XIU, chemically known as 2,4(1h,3h)-pyrimidinedione, 5-ethynyl- but generally known as eniluracil, which bears US NIH Compound Identifier 43157. European Medicines Agency schedules Eniluracil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13674MIG. The term ENILURACIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 1 1998, List 39). ENILURACIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eniluracil under HS 29335995 and SITC 51576. As of Q4 2014, ENILURACIL remains the US FDA Preferred Term for this commodity. Eniluracil bears US NLM identifiers UMLS ID C0098361 and NCI Concept Code C1773. SMILES: O=C1[NH]C(=O)[NH]CC1C#C.

